We compared the outcome of postoperative unilateral cervical nodes radiotherapy (UL-RT) vs bilateral cervical nodes plus total mucosal irradiation (COMP-RT) in the management of head and neck carcinoma of unknown primary (HNCUP).

Methods

HNCUP, defined by the absence of primary despite a PET-CT combined with a panendoscopy, were treated with curative intent by initial ipsilateral neck dissection. Sixty-nine patients with unilateral HNCUP were included: 23 received UL-RT while 46 received COMP-RT. Carcinologic outcomes and long-term quality of life (QOL) according to the QOL Questionnaire for Head and Neck 35 were assessed.

Results

Within 6.3 years of median follow-up, there was no significant difference in primary tumor emergence rate (P = .68), cervical node recurrence rate (P = .34), or overall survival (P = .33) between UL-RT and COMP-RT groups. A trend toward QOL improvement was observed in the UL-RT group.

Conclusion

UL-RT seems to provide similar outcomes as COMP-RT in unilateral HNCUP management.

REFERENCES

1 Union for International Cancer Control (UICC). TNM Classification of-Malignant Tumours 8th edition.
Google Scholar
2Grau C, Johansen LV, Jakobsen J, Geertsen P, Andersen E, Jensen BB. Cervical lymph node metastases from unknown primary tumours. Radiother Oncol. 2000; 55(2): 121-129.
10.1016/S0167-8140(00)00172-9
CAS PubMed Web of Science® Google Scholar
3Varadhachary GR. Carcinoma of unknown primary origin. Gastrointest Cancer Res GCR. 2007; 1(6): 229-235.
PubMed Google Scholar
4van de Wouw AJ. The unknown biology of the unknown primary tumour: a literature review. Ann Oncol. 2003; 14(2): 191-196.
10.1093/annonc/mdg068
PubMed Web of Science® Google Scholar
5Liu X, Li D, Li N, Zhu X. Optimization of radiotherapy for neck carcinoma metastasis from unknown primary sites: a meta-analysis. Oncotarget. 2016 Oct 24; 7(48): 78736-78746.
10.18632/oncotarget.12852
PubMed Google Scholar
6Amsbaugh MJ, Yusuf M, Gaskins J, et al. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation. Am J Otolaryngol. 2017; 38(5): 588-592.
10.1016/j.amjoto.2017.06.006
PubMed Web of Science® Google Scholar
7Shoushtari A, Saylor D, Kerr K-L, et al. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2011; 81(3): e83-e91.
10.1016/j.ijrobp.2011.01.014
PubMed Web of Science® Google Scholar
8Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17(6): 1471-1474.
10.1245/s10434-010-0985-4
PubMed Web of Science® Google Scholar
9SCManualQLQ-C30.pdf, https://www.eortc.be/qol/files/SCManualQLQ-C30.pdf. Accessed August 22, 2018.
Google Scholar
10Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and Treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31(5): 1341-1346.
10.1016/0360-3016(95)00060-C
CAS PubMed Web of Science® Google Scholar
11 National Comprehensive Cancer Network. NCCN clinicalpractice guidelines in Oncology, Head and Neck Cancers. https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf. Accessed October 20, 2018.
Google Scholar
12Mackenzie K, Watson M, Jankowska P, Bhide S, Simo R. Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; 130(S2): S170-S175.
10.1017/S0022215116000591
CAS PubMed Web of Science® Google Scholar
13Straetmans J, Vent J, Lacko M, et al. Management of neck metastases of unknown primary origin united in two European centers. Eur Arch Otorhinolaryngol. 2015 Jan; 272(1): 195-205.
10.1007/s00405-014-2934-5
PubMed Web of Science® Google Scholar
14Perkins SM, Spencer CR, Chernock RD, et al. Radiotherapeutic management of cervical lymph node metastases from an unknown primary site. Arch Otolaryngol Head Neck Surg. 2012 Jul; 138(7): 656-661.
10.1001/archoto.2012.1110
PubMed Google Scholar
15Fakhrian K, Thamm R, Knapp S, et al. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. a retrospective analysis. Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al. 2012 Jan; 188(1): 56-61.
10.1007/s00066-011-0017-8
CAS PubMed Web of Science® Google Scholar
16Daly PE, McArdle O, Armstrong JG, et al. Can we avoid bilateral radiation therapy in head-and-neck carcinoma of unknown primary in the PET-CT era? Int J Rad Oncol Biol Phys. 2018; 84(3):S520. https://www.redjournal.org/article/S0360-3016(12)02333-4/abstract, Accessed August 29.
Google Scholar
17Richards TM, Bhide SA, Miah AB, et al. Total mucosal irradiation with intensity-modulated radiotherapy in patients with head and neck carcinoma of unknown primary: a pooled analysis of two prospective studies. Clin Oncol R Coll Radiol G B. 2016 Sep; 28(9): e77-e84.
10.1016/j.clon.2016.04.035
CAS PubMed Web of Science® Google Scholar
18Johansen J, Petersen H, Godballe C, Loft A, Grau C. FDG-PET/CT for detection of the unknown primary head and neck tumor. Q J Nucl Med Mol Imaging off Publ Ital Assoc Nucl Med AIMN Int Assoc Radiopharmacol IAR Sect Soc. 2011; 55(5): 500-508.
CAS Google Scholar
19Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer. 2004; 101(11): 2641-2649.
10.1002/cncr.20687
PubMed Web of Science® Google Scholar
20de Ridder M, Klop M, Hamming-Vrieze O, et al. Unknown primary head and neck squamous cell carcinoma in the era of fluorodeoxyglucose-positron emission tomography/CT and intensity-modulated radiotherapy. Head Neck. 2017; 39(7): 1382-1391.
10.1002/hed.24762
PubMed Web of Science® Google Scholar
21Ligey A, Gentil J, Créhange G, et al. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol J Eur Soc Ther Radiol Oncol. 2009 Dec; 93(3): 483-487.
10.1016/j.radonc.2009.08.027
CAS PubMed Web of Science® Google Scholar
22Dragan AD, Nixon IJ, Guerrero-Urbano MT, Oakley R, Jeannon J-P, Simo R. Selective neck dissection as a therapeutic option in management of squamous cell carcinoma of unknown primary. Eur Arch Otorhinolaryngol. 2014; 271(5): 1249-1256.
10.1007/s00405-013-2643-5
PubMed Web of Science® Google Scholar
23Hu KS, Mourad WF, Gamez ME, et al. Five-year outcomes of an oropharynx-directed treatment approach for unknown primary of the head and neck. Oral Oncol. 2017 Jul; 70: 14-22.
10.1016/j.oraloncology.2017.05.001
PubMed Web of Science® Google Scholar
24Al Kadah B, Papaspyrou G, Linxweiler M, et al. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch Otorhinolaryngol. 2017 Jun; 274(6): 2557-2566.
10.1007/s00405-017-4525-8
PubMed Web of Science® Google Scholar
25Dünne AA, Müller HH, Eisele DW, Keßel K, Moll R, Werner JA. Meta-analysis of the prognostic significance of perinodal spread in head and neck squamous cell carcinomas (HNSCC) patients. Eur J Cancer. 2006 Aug; 42(12): 1863-1868.
10.1016/j.ejca.2006.01.062
CAS PubMed Web of Science® Google Scholar
26Sinnathamby K, Peters L, Laidlaw C, Hughes P. The occult head and neck primary: to treat or not to treat? Clin Oncol. 1997; 9(5): 322-329.
10.1016/S0936-6555(05)80066-4
CAS Google Scholar
27Colletier PJ, Garden AS, Morrison WH, Goepfert H, Geara F, Ang KK. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure. Head Neck. 1998; 20(8): 674-681.
10.1002/(SICI)1097-0347(199812)20:8<674::AID-HED3>3.0.CO;2-H
CAS PubMed Web of Science® Google Scholar
28Rathod S, Gupta T, Ghosh-Laskar S, Murthy V, Budrukkar A, Agarwal J. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Oral Oncol. 2013; 49(6): 634-642.
10.1016/j.oraloncology.2013.02.013
PubMed Web of Science® Google Scholar

Citing Literature

Volume42, Issue2

February 2020

Pages 302-311

Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes

Abstract

Background

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes

Abstract

Background

Methods

Results

Conclusion

REFERENCES

Citing Literature

References

Related

Information